The world's latest technology in cervical screening. Learn more
VIDEO: TS in Russia - Chechnya Hospital Visit, March 2020
TruScreen is pleased to advise that it has received approval from the MOH of the Vietnam Government for the commercial roll-out of the TruScreen cervical…
Real time cervical cancer screening technology company TruScreen (NZX: TRU or ”Company”) is pleased to provide it's April market update on its various commercial operations.
Despite considerable progress in the past decades, societies continue to fail to meet the healthcare needs of women at key moments in their lives.
TruScreen Limited (NZX:TRU) is pleased to announce the appointment of Ms Victoria Potarina as Chief Executive Officer, commencing 2 March 2020.
The Company has appointed RSM Hayes Audit Auckland as auditors of the Company with immediate effect.
Cervical cancer is epidemic in India, with 77,300 new cases diagnosed each year and 37,800 deaths resulting from the disease—a fatality rate of 49 per…
China manufacturing approvals expected to provide TruScreen greater market access. Local manufacturing contracts in China under negotiation with expected reduction in component costs. Novel Coronavirus…
"A novel diagnostic device for cervical cancer screening in India."